Table 4.
Risk factors associated with first bacteremia episode.
| Univariate |
Multivariate |
|||
|---|---|---|---|---|
| Variables | HR (95% CI) | p | HR (95% CI) | p |
| Graft source | ||||
| Bone marrow | 1 | 1 | 1 | 1 |
| Peripheral blood | 1.01 (0.56–1.83) | 0.97 | 1.88 (0.41–8.53) | 0.41 |
| Cord blood | 1.39 (0.32–5.9) | 0.65 | 1.47 (0.77–2.82) | 0.24 |
| Underlying disease: malignant | 0.98 (0.49–1.99) | 0.97 | 1.67 (0.66–4.18) | 0.27 |
| Allogeneic stem cell transplant | 2.47 (0.88–6.91) | 0.08 | 3.00(0.88–10.19) | 0.08 |
| Myeloablative conditioning | 0.58 (0.33–1.04) | 0.07 | 0.68 (0.31–1.48) | 0.34 |
| Previous antibiotic use | 0.95 (0.51–1.68) | 0.82 | 0.85 (0.45–1.58) | 0.27 |
| Carbapenem-resistant Enterobacteriaceae colonization | 1.55 (0.47–5.10) | 0.46 | – | – |
| Mucositis moderate/severe | 1.37 (0.64–2.92) | 0.42 | 1.25 (0.56–2.78) | 0.55 |
| aGVHD | 1.43 (0.75–2.73) | 0.27 | – | – |
| aGVHD III-IV | 1.46 (0.57–3.72) | 0.43 | – | – |
aGvHD: Acute graft-versus-host disease.